All the news Showing 5 of 15 articles from: Deciding when and how to treat HCVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Low uptake of HCV treatment in England will lead to substantial disease burden by 2035 Michael Carter / 24 June 2014 Only 3% of people with chronic hepatitis C virus (HCV) are treated for their infection each year in England, according to research published in the Journal of Hepatology. The current uptake of ... Model shows that HCV therapy for patients with more severe fibrosis cost-effective in Egypt Michael Carter / 24 February 2014 Lack of resources means that Egypt should prioritise hepatitis C virus (HCV) treatment for patients with more advanced disease, according to a mathematical model published in the online edition of Clinical Infectious Diseases. Therapy ... People with HIV/HCV co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease Michael Carter / 10 September 2013 People living with HIV who have hepatitis C virus (HCV) co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease even though they do not have cirrhosis of the liver, ... Fear of future health problems encourage people to start and complete HCV therapy but concern about side-effects is a deterrent Michael Carter / 27 June 2013 US research has provided important insights into the factors that motivate and deter people from starting and completing therapy for hepatitis C virus (HCV) infection. Published in the online journal BMC Infectious Diseases, the ... Low viral load in hepatitis C treatment: Is a third drug necessary? Rob Camp / 23 November 2012 When resources for hepatitis C treatment with new directly acting antivirals are limited, findings from the United States suggest that previously untreated people with low viral loads may stand a good chance ... ← Prev12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive